Published in Infect Immun on September 01, 2004
Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med (2007) 2.85
The capsule of the fungal pathogen Cryptococcus neoformans. Adv Appl Microbiol (2009) 1.97
Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J Exp Med (2009) 1.84
Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi. PLoS Pathog (2007) 1.55
Toll-like receptor interactions: tolerance of MyD88-dependent cytokines but enhancement of MyD88-independent interferon-beta production. Immunology (2006) 1.37
The Toll-like receptors: analysis by forward genetic methods. Immunogenetics (2005) 1.31
The Role of TLR2 in Infection and Immunity. Front Immunol (2012) 1.28
Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans. Eur J Immunol (2012) 1.24
Role of the mannose receptor in a murine model of Cryptococcus neoformans infection. Infect Immun (2008) 1.17
Both TLR2 and TLR4 are required for the effective immune response in Staphylococcus aureus-induced experimental murine brain abscess. Am J Pathol (2007) 1.16
Importance of TLR2 in early innate immune response to acute pulmonary infection with Porphyromonas gingivalis in mice. J Immunol (2008) 1.16
Toll-like receptor 4 signaling leads to severe fungal infection associated with enhanced proinflammatory immunity and impaired expansion of regulatory T cells. Infect Immun (2009) 1.08
Klebsiella pneumoniae increases the levels of Toll-like receptors 2 and 4 in human airway epithelial cells. Infect Immun (2008) 1.07
Toll-like receptors (TLRs) expression and function in response to inactivate hyphae of Fusarium solani in immortalized human corneal epithelial cells. Mol Vis (2007) 1.05
The presence of CD14 overcomes evasion of innate immune responses by virulent Francisella tularensis in human dendritic cells in vitro and pulmonary cells in vivo. Infect Immun (2009) 1.03
Immunomodulatory effects of serotype B glucuronoxylomannan from Cryptococcus gattii correlate with polysaccharide diameter. Infect Immun (2010) 0.98
Enhanced innate immune responsiveness to pulmonary Cryptococcus neoformans infection is associated with resistance to progressive infection. Infect Immun (2008) 0.98
MyD88-dependent TLR4 signaling is selectively impaired in alveolar macrophages from asymptomatic HIV+ persons. Blood (2010) 0.96
Early induction of CCL7 downstream of TLR9 signaling promotes the development of robust immunity to cryptococcal infection. J Immunol (2012) 0.96
Macrophage autophagy in immunity to Cryptococcus neoformans and Candida albicans. Infect Immun (2012) 0.95
Fungal pathogens-a sweet and sour treat for toll-like receptors. Front Cell Infect Microbiol (2012) 0.92
Defect of CARD9 leads to impaired accumulation of gamma interferon-producing memory phenotype T cells in lungs and increased susceptibility to pulmonary infection with Cryptococcus neoformans. Infect Immun (2014) 0.90
Cryptococcus-Related Immune Reconstitution Inflammatory Syndrome(IRIS): Pathogenesis and Its Clinical Implications. Curr Fungal Infect Rep (2011) 0.90
Contributions of the MyD88-dependent receptors IL-18R, IL-1R, and TLR9 to host defenses following pulmonary challenge with Cryptococcus neoformans. PLoS One (2011) 0.90
Classical versus alternative macrophage activation: the Ying and the Yang in host defense against pulmonary fungal infections. Mucosal Immunol (2014) 0.90
Binding of glucuronoxylomannan to the CD14 receptor in human A549 alveolar cells induces interleukin-8 production. Clin Vaccine Immunol (2006) 0.89
Cryptococcus gattii induces a cytokine pattern that is distinct from other cryptococcal species. PLoS One (2013) 0.85
A purified capsular polysaccharide markedly inhibits inflammatory response during endotoxic shock. Infect Immun (2012) 0.85
Early ART After Cryptococcal Meningitis Is Associated With Cerebrospinal Fluid Pleocytosis and Macrophage Activation in a Multisite Randomized Trial. J Infect Dis (2015) 0.83
Fungal pathogen recognition by scavenger receptors in nematodes and mammals. Virulence (2010) 0.82
Biophysical methods for the study of microbial surfaces. Front Microbiol (2011) 0.81
Cd14 SNPs regulate the innate immune response. Mol Immunol (2012) 0.80
Binding of the wheat germ lectin to Cryptococcus neoformans chitooligomers affects multiple mechanisms required for fungal pathogenesis. Fungal Genet Biol (2013) 0.79
Anti-Immune Strategies of Pathogenic Fungi. Front Cell Infect Microbiol (2016) 0.79
Spleen deposition of Cryptococcus neoformans capsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1. Med Mycol (2008) 0.79
Cryptococcus and Phagocytes: Complex Interactions that Influence Disease Outcome. Front Microbiol (2016) 0.79
MyD88-dependent signaling drives host survival and early cytokine production during Histoplasma capsulatum infection. Infect Immun (2015) 0.78
Genetic variants of innate immune receptors and infections after liver transplantation. World J Gastroenterol (2014) 0.77
Toll-like receptor 9-dependent activation of bone marrow-derived dendritic cells by URA5 DNA from Cryptococcus neoformans. Infect Immun (2011) 0.77
Clearance of Pneumocystis murina infection is not dependent on MyD88. Microbes Infect (2014) 0.76
Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct. Future Microbiol (2014) 0.76
Co-regulation of Dectin-1 and TLR2 in inflammatory response of human corneal epithelial cells induced by Aspergillus fumigates. Int J Ophthalmol (2016) 0.76
DAP12 Inhibits Pulmonary Immune Responses to Cryptococcus neoformans. Infect Immun (2016) 0.75
TLR2(-/-) Mice Display Increased Clearance of Dermatophyte Trichophyton mentagrophytes in the Setting of Hyperglycemia. Front Cell Infect Microbiol (2017) 0.75
The Cell Biology of the Trichosporon-Host Interaction. Front Cell Infect Microbiol (2017) 0.75
Genetic Diversity of CD14 Promoter Gene Polymorphism (rs2569190) is Associated With Regulation of Malaria Parasitemia and Susceptibility to Plasmodium falciparum Infection. Infect Dis (Auckl) (2017) 0.75
Innate Immune Responses to Cryptococcus. J Fungi (Basel) (2017) 0.75
Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol (2001) 18.80
Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity (1998) 18.12
Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity (1999) 17.40
Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol (1999) 16.86
Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity (1999) 11.64
Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol (2000) 6.61
The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis (2002) 3.46
Toll-like receptor signaling. J Biol Chem (2003) 3.24
The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol (2004) 3.21
Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol (2004) 3.13
Cryptococcosis. Infect Dis Clin North Am (2002) 3.01
Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol (2002) 2.67
Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect Immun (1998) 2.60
Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. J Immunol (2004) 2.26
T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect Immun (1991) 2.17
Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol (1996) 2.12
MyD88 primes macrophages for full-scale activation by interferon-gamma yet mediates few responses to Mycobacterium tuberculosis. J Exp Med (2003) 2.10
IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6). J Immunol (1998) 1.93
The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14. J Immunol (1995) 1.91
Candida albicans phospholipomannan is sensed through toll-like receptors. J Infect Dis (2003) 1.91
Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J Infect Dis (2003) 1.91
Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem (2002) 1.87
Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes. Infect Immun (1995) 1.86
Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell Microbiol (2003) 1.86
Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J Immunol (2000) 1.84
Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. J Immunol (2001) 1.84
Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J Immunol (1995) 1.80
Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect Immun (2001) 1.75
IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am J Respir Cell Mol Biol (1997) 1.71
Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin. J Clin Invest (1991) 1.70
Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans. J Immunol (1989) 1.69
Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am J Respir Cell Mol Biol (1995) 1.59
Saccharomyces cerevisiae- and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14- and Toll-like receptor 4-dependent manner. Microbiol Immunol (2002) 1.57
Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors. J Immunol (2002) 1.56
IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin Exp Immunol (1996) 1.45
Cryptococcal polysaccharides bind to CD18 on human neutrophils. Infect Immun (1997) 1.41
Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation. Infect Immun (1995) 1.41
Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. Microbes Infect (2004) 1.40
Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect Immun (1997) 1.39
Experimental murine pulmonary cryptococcosis. Differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans. Lab Invest (1994) 1.37
Cryptococcal infection and Th1-Th2 cytokine balance. Int Rev Immunol (2002) 1.36
Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates. Infect Immun (1999) 1.35
In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: a critical role for tissue macrophages. J Infect Dis (2001) 1.24
Regulatory effects of macrophage inflammatory protein 1alpha/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines. Infect Immun (2001) 1.22
IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells. J Immunol (2000) 1.17
Contribution of interferon-gamma in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans. FEMS Immunol Med Microbiol (1996) 1.17
The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation. J Leukoc Biol (2003) 1.17
Effects of the capsular polysaccharides of Cryptococcus neoformans on phagocyte migration and inflammatory mediators. Curr Med Chem (2004) 1.16
Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma-inducing cytokines. Cell Immunol (1999) 1.10
Protective efficacy of antigenic fractions in mouse models of cryptococcosis. Infect Immun (2004) 1.03
Role of interleukin-4 in resistance to Cryptococcus neoformans infection. Am J Respir Cell Mol Biol (2003) 1.01
Protective cell-mediated immunity against Cryptococcus neoformans. Res Immunol (1998) 1.01
Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils. Eur J Immunol (2003) 1.00
Reduced host resistance and Th1 response to Cryptococcus neoformans in interleukin-18 deficient mice. FEMS Microbiol Lett (2000) 0.99
Mechanism of action of antibody to capsular polysaccharide in Cryptococcus neoformans infection. Front Biosci (1998) 0.96
Chemokine responses and accumulation of inflammatory cells in the lungs of mice infected with highly virulent Cryptococcus neoformans: effects of interleukin-12. FEMS Immunol Med Microbiol (1999) 0.92
Trophic slime, allergic slime. Am J Respir Cell Mol Biol (2000) 0.83
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Hidden killers: human fungal infections. Sci Transl Med (2012) 7.10
The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol (2004) 3.21
Tackling human fungal infections. Science (2012) 2.49
Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J Immunol (2008) 2.29
The immune response to fungal infections. Br J Haematol (2005) 2.24
Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol (2011) 2.12
Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis (2010) 1.98
Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem (2002) 1.87
Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Ther Clin Risk Manag (2008) 1.79
Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J Clin Microbiol (2004) 1.78
MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting. Clin Infect Dis (2014) 1.78
A chitin synthase and its regulator protein are critical for chitosan production and growth of the fungal pathogen Cryptococcus neoformans. Eukaryot Cell (2005) 1.76
Programmed death-1 targeting can promote allograft survival. J Immunol (2002) 1.68
Acute bacterial suppurative thyroiditis: a clinical review and expert opinion. Thyroid (2010) 1.65
Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors. J Immunol (2002) 1.56
The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J Biol Chem (2003) 1.55
A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. Cell Host Microbe (2011) 1.41
Cryptococcus neoformans Kin1 protein kinase homologue, identified through a Caenorhabditis elegans screen, promotes virulence in mammals. Mol Microbiol (2004) 1.39
Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells. J Immunol (2006) 1.32
Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA. Infect Immun (2008) 1.30
Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists. Infect Immun (2009) 1.29
Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains. Infect Immun (2003) 1.27
Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathog (2006) 1.27
Interactions of fungi with phagocytes. Curr Opin Microbiol (2002) 1.24
Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles. MBio (2010) 1.22
Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates. Antimicrob Agents Chemother (2014) 1.21
In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis. Infect Immun (2006) 1.21
Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit. Mycoses (2011) 1.20
Innate recognition of cell wall β-glucans drives invariant natural killer T cell responses against fungi. Cell Host Microbe (2011) 1.18
Role of the mannose receptor in a murine model of Cryptococcus neoformans infection. Infect Immun (2008) 1.17
A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity. J Immunol (2005) 1.17
Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans. Infect Immun (2005) 1.17
Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses. Infect Immun (2002) 1.12
The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis. J Infect Dis (2013) 1.11
KRE5 gene null mutant strains of Candida albicans are avirulent and have altered cell wall composition and hypha formation properties. Eukaryot Cell (2004) 1.10
IL-33 mediates multi-walled carbon nanotube (MWCNT)-induced airway hyper-reactivity via the mobilization of innate helper cells in the lung. Nanotoxicology (2012) 1.09
Innate sensing of chitin and chitosan. PLoS Pathog (2013) 1.09
Cytomegalovirus: prophylaxis, preemption, or "wait and watch". Liver Transpl (2012) 1.08
Relative contributions of dectin-1 and complement to immune responses to particulate β-glucans. J Immunol (2012) 1.07
Cryptococcus neoformans enters the endolysosomal pathway of dendritic cells and is killed by lysosomal components. Infect Immun (2008) 1.07
Protective efficacy of antigenic fractions in mouse models of cryptococcosis. Infect Immun (2004) 1.03
Chitosan but not chitin activates the inflammasome by a mechanism dependent upon phagocytosis. J Biol Chem (2011) 1.02
Contribution of glycosylation to T cell responses stimulated by recombinant Cryptococcus neoformans mannoprotein. J Infect Dis (2007) 1.02
Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans. MBio (2011) 0.99
The pharmacology and clinical use of caspofungin. Expert Opin Drug Metab Toxicol (2007) 0.99
Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors. Clin Cancer Res (2009) 0.97
Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis. Infect Immun (2012) 0.97
The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts. Clin Infect Dis (2013) 0.97
Cooperative stimulation of dendritic cells by Cryptococcus neoformans mannoproteins and CpG oligodeoxynucleotides. PLoS One (2008) 0.97
Effect of differential N-linked and O-linked mannosylation on recognition of fungal antigens by dendritic cells. PLoS One (2007) 0.97
Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines. Vaccine (2007) 0.96
Isolation and purification of antigenic components of Cryptococcus. Methods Mol Biol (2009) 0.96
Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo. Infect Immun (2005) 0.94
Disruption of the ICOS-B7RP-1 costimulatory pathway leads to enhanced hepatic immunopathology and increased gamma interferon production by CD4 T cells in murine schistosomiasis. Infect Immun (2003) 0.94
Monocyte- and macrophage-targeted NADPH oxidase mediates antifungal host defense and regulation of acute inflammation in mice. J Immunol (2013) 0.93
Butyrophilin-like 2 modulates B7 costimulation to induce Foxp3 expression and regulatory T cell development in mature T cells. J Immunol (2013) 0.92
Prospects for development of vaccines against fungal diseases. Drug Resist Updat (2006) 0.91
Inhibition of mitogen-activated protein kinase signaling by chloroquine. J Immunol (2002) 0.90
Pulmonary zygomycosis. Semin Respir Crit Care Med (2008) 0.90
Contributions of the MyD88-dependent receptors IL-18R, IL-1R, and TLR9 to host defenses following pulmonary challenge with Cryptococcus neoformans. PLoS One (2011) 0.90
Toll-like receptor 9 modulates macrophage antifungal effector function during innate recognition of Candida albicans and Saccharomyces cerevisiae. Infect Immun (2011) 0.90
Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 0.89
Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-γ responses before antiretroviral therapy but not higher T-cell responses during therapy. J Infect Dis (2013) 0.89
Characterization and optimization of the glucan particle-based vaccine platform. Clin Vaccine Immunol (2013) 0.88
IL-22 regulates iron availability in vivo through the induction of hepcidin. J Immunol (2013) 0.88
Cryptococcus: the once-sleeping giant is fully awake. FEMS Yeast Res (2006) 0.87
Use of fungal derived polysaccharide-conjugated particles to probe Dectin-1 responses in innate immunity. Integr Biol (Camb) (2011) 0.87
Amikacin and colistin for treatment of Acinetobacter baumannii meningitis. J Infect (2005) 0.86
Immunogenicity/hypersensitivity of biologics. Toxicol Pathol (2013) 0.84
Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans. Virulence (2010) 0.84
Early serum (1→3)-β-D-glucan levels in patients with burn injury. Mycoses (2011) 0.84
Dynamic virulence: real-time assessment of intracellular pathogenesis links Cryptococcus neoformans phenotype with clinical outcome. MBio (2011) 0.83
Modulatory role of vitamin A on the Candida albicans-induced immune response in human monocytes. Med Microbiol Immunol (2014) 0.82
AMG 900, a small-molecule inhibitor of aurora kinases, potentiates the activity of microtubule-targeting agents in human metastatic breast cancer models. Mol Cancer Ther (2013) 0.81
Effects of immunomodulatory and organism-associated molecules on the permeability of an in vitro blood-brain barrier model to amphotericin B and fluconazole. Antimicrob Agents Chemother (2009) 0.81
Pneumocystis pneumonia in children. Paediatr Respir Rev (2009) 0.81
Use of an optical trap for study of host-pathogen interactions for dynamic live cell imaging. J Vis Exp (2011) 0.80
CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 32-2015. A 57-Year-Old Man with Severe Pneumonia and Hypoxemic Respiratory Failure. N Engl J Med (2015) 0.80
Epidemiology of bloodstream infections in burn-injured patients: a review of the national burn repository. J Burn Care Res (2010) 0.80
Evaluation of mupA Evigene in comparison to disk diffusion for detection of high-level mupirocin resistance in clinical isolates of Staphylococcus aureus. J Clin Microbiol (2010) 0.79
Diagnostic imaging of experimental invasive pulmonary aspergillosis. Med Mycol (2009) 0.79
Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection. Transplantation (2016) 0.78
Cryptococcus neoformans prosthetic joint infection: case report and review of the literature. Mycopathologia (2014) 0.78
Candida bloodstream infections in hemodialysis recipients. Med Mycol (2009) 0.77
ICOS and B7 costimulatory molecule expression identifies activated cellular subsets in rheumatoid arthritis. Cytometry A (2007) 0.77
NKp30 enables NK cells to act naturally with fungi. Cell Host Microbe (2013) 0.77
A chronological history of the International Conference on Cryptococcus and Cryptococcosis (ICCC), an invaluable forum for growth of the cryptococcal research field and clinical practice. Mycopathologia (2011) 0.76
Toll-like receptor 4 polymorphisms and aspergillosis. N Engl J Med (2009) 0.75
Personalized medicine. Is it time for infectious diseases? Saudi Med J (2016) 0.75
Diagnostic and therapeutic challenges in a liver transplant recipient with central nervous system invasive aspergillosis. Diagn Microbiol Infect Dis (2012) 0.75
Phomopsis bougainvilleicola prepatellar bursitis in a renal transplant recipient. J Clin Microbiol (2012) 0.75
Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. Clin Infect Dis (2006) 0.75
Leveraging the unique expertise of our clinical colleagues: a real-world example for collaborative harnessing of the National Burn Repository. J Burn Care Res (2008) 0.75